Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies

被引:7
作者
Cohn, ML [1 ]
Waites, KB [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA
关键词
D O I
10.1128/AAC.45.7.2126-2128.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We determined in vitro activities of gatifloxacin and seven other drugs against 100 isolates of Stenotrophomonas maltophilia using the agar gradient diffusion (Etest) method. Percentages of susceptible isolates were as follows: trimethoprim-sulfamethoxazole, 90%; gatifloxacin, 71%; levofloxacin, 57%; ticarcillin clavulanic acid, 54%; ceftazidime, 49%; ciprofloxacin, 29%; cefepime, 21%; and piperacillin-tazobactam, 20%. Time kill studies of three isolates indicated that gatifloxacin was bactericidal at times as early as 3 h of incubation when tested at concentrations equivalent to twice the MIC (two isolates) and 4 times the MIC (one isolate).
引用
收藏
页码:2126 / 2128
页数:3
相关论文
共 13 条
  • [1] Antimicrobial activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia spp.
    Biedenbach, DJ
    Jones, RN
    Marshall, SA
    Johnson, DM
    Croco, MAT
    [J]. DRUGS, 1999, 58 (Suppl 2) : 180 - 181
  • [2] Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates
    Bonfiglio, G
    Cascone, C
    Azzarelli, C
    Cafiso, V
    Marchetti, F
    Stefani, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) : 115 - 117
  • [3] Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
    Denton, M
    Kerr, KG
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) : 57 - +
  • [4] Susceptibility of Stenotrophomonas maltophilia to moxifloxacin, trovafloxacin, ofloxacin and ciprofloxacin
    Hawley, HB
    Polenakovik, HM
    Czachor, JS
    Mueller, SS
    [J]. DRUGS, 1999, 58 (Suppl 2) : 214 - 216
  • [5] Jang Tsrang-Neng, 1992, Journal of the Formosan Medical Association, V91, P1170
  • [6] INVITRO SUSCEPTIBILITY OF XANTHOMONAS-(PSEUDOMONAS)-MALTOPHILIA TO NEWER ANTIMICROBIAL AGENTS
    KHARDORI, N
    REUBEN, A
    ROSENBAUM, B
    ROLSTON, K
    BODEY, GP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) : 1609 - 1610
  • [7] SUSCEPTIBILITY OF XANTHOMONAS-MALTOPHILIA TO 6 QUINOLONES AND STUDY OF OUTER-MEMBRANE PROTEINS IN RESISTANT MUTANTS SELECTED INVITRO
    LECSOBORNET, M
    PIERRE, J
    SARKISKARAM, D
    LUBERA, S
    BERGOGNEBEREZIN, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) : 669 - 671
  • [8] National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS
  • [9] SUSCEPTIBILITIES OF 123 STRAINS OF XANTHOMONAS-MALTOPHILIA TO 8 BETA-LACTAMS (INCLUDING BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATIONS) AND CIPROFLOXACIN TESTED BY 5 METHODS
    PANKUCH, GA
    JACOBS, MR
    RITTENHOUSE, SF
    APPELBAUM, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) : 2317 - 2322
  • [10] Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics
    Schmitz, FJ
    Sadurski, R
    Verhoef, J
    Milatovic, D
    Fluit, AC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 921 - 924